MYX mayne pharma group limited

What MYX chart shouts, page-459

  1. 335 Posts.
    lightbulb Created with Sketch. 266
    There's a lot of focus on the flat performance of WH in the last half of FY24, and rightly so, but I think there were some signs that things were improving in the last quarter of FY24 here are two clips from the FY24 report

    https://hotcopper.com.au/data/attachments/6605/6605307-688d8c1e7363570f799d464ec3e2401b.jpg
    There was a US$7.2M legacy issue for Annovera which accounted for the flat performance.

    As far as Nextstellis goes there was a 10.4% QoQ improvement in the last quarter suggesting things were beginning to turn around. Comment related to Nextstellis.
    https://hotcopper.com.au/data/attachments/6605/6605317-5b6f87616f778b334b3c8c7453ce2d7e.jpg
    Should there be a follow through with these two in the first 4 mths of FY25, we will see a significant turnaround in profitability, of course no follow through means we are back to $4.

    There was just a small hint of what's coming from the CEO during the last presentation when he said at the end of question time...

    " ... this is going to help us to continue this remarkable turnaround that we've had so far and surprise the market with our continued growth to profitabilty"



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.22
Change
0.140(2.76%)
Mkt cap ! $424.1M
Open High Low Value Volume
$5.15 $5.32 $5.10 $1.806M 346.1K

Buyers (Bids)

No. Vol. Price($)
2 12140 $5.22
 

Sellers (Offers)

Price($) Vol. No.
$5.29 6600 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.